TAZOCEL Side Effects

6967222-7 | Hepatotoxicity, Neutropenia
on Sep 01, 2010 Male patient from SPAIN , 48 years of age, was diagnosed with postoperative wound infection, pain (What is pain?), hyperlipidaemia, type 2 diabetes mellitus and was treated with Tazocel (View Usage). Patient experienced the following unwanted or unexpected effects: hepatotoxicity, neutropenia. Tazocel dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), METFORMIN (View Metformin Review and Metformin Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), HUMULINA (View Humulina Review and Humulina Label ), BEMIPARIN SODIUM (View Bemiparin Sodium Review and Bemiparin Sodium Label ).

6964638-X | Coagulopathy, Post Procedural Haemorrhage
Patient was taking Tazocel (View Usage). Patient had the following side effects: coagulopathy, post procedural haemorrhage on Aug 31, 2010 from SPAIN Additional patient health information: Male patient , child 4 years of age, was diagnosed with infection prophylaxis, hypertension and. Tazocel dosage: . During the same period patient was treated with NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ).

6915136-0 | Eosinophilia, Neutropenia, Pyrexia, Rash, Tubulointerstitial Nephritis
Adverse event was reported on Aug 04, 2010 by a Female patient taking Tazocel (View Usage) (Dosage: ) was diagnosed with device related infection, pain (What is pain?), depression (What is depression?) and. Location: SPAIN , 67 years of age, After Tazocel was administered, patient had the following side effects: eosinophilia, neutropenia, pyrexia, rash (What is rash?), tubulointerstitial nephritis. During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ).

6549014-6 | Toxic Skin Eruption
on Jan 21, 2010 Male patient from SPAIN , child 1 years of age, was diagnosed with respiratory tract infection and was treated with Tazocel (View Usage). Patient experienced the following unwanted or unexpected effects: toxic skin eruption. Tazocel dosage: . During the same period patient was treated with PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), NOLOTIL /SPA/ (View Nolotil /spa/ Review and Nolotil /spa/ Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ). Patient was hospitalized.


6457820-1 | Hepatitis Cholestatic, Renal Failure Acute
on Nov 19, 2009 Male patient from SPAIN , 58 years of age, was diagnosed with osteitis and was treated with Tazocel (View Usage). Patient had the following side effects: hepatitis cholestatic, renal failure acute. Tazocel dosage: . During the same period patient was treated with HIBOR (View Hibor Review and Hibor Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6435193-8 | Hypocalcaemia, Hypokalaemia, Metabolic Alkalosis, Metabolic Encephalopathy
Patient was taking Tazocel (View Usage). After Tazocel was administered, patient had the following side effects: hypocalcaemia, hypokalaemia, metabolic alkalosis, metabolic encephalopathy on Nov 05, 2009 from SPAIN Additional patient health information: Female patient , 72 years of age, was diagnosed with infection (What is infection?), atrial fibrillation (What is atrial fibrillation?), bronchospasm, convulsion and. Tazocel dosage: . During the same period patient was treated with PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), SEGURIL (View Seguril Review and Seguril Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CLOXACILLIN (View Cloxacillin Review and Cloxacillin Label ), URBASON (View Urbason Review and Urbason Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

6424498-2 | Face Oedema, Rash
Adverse event was reported on Oct 29, 2009 by a Male patient taking Tazocel (View Usage) (Dosage: ) was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Location: SPAIN , 75 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: face oedema, rash (What is rash?). During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), DALACIN FOSFATO (View Dalacin Fosfato Review and Dalacin Fosfato Label ).

6414606-1 | Atrial Fibrillation, Bronchospasm, Convulsion, Hypocalcaemia, Hypokalaemia, Metabolic Alkalosis, Metabolic Encephalopathy, Somnolence
on Oct 22, 2009 Female patient from SPAIN , 72 years of age, was diagnosed with infection (What is infection?), atrial fibrillation (What is atrial fibrillation?), bronchospasm, convulsion and was treated with Tazocel (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), bronchospasm, convulsion, hypocalcaemia, hypokalaemia, metabolic alkalosis, metabolic encephalopathy, somnolence. Tazocel dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), CLEXANE (View Clexane Review and Clexane Label ), SEGURIL (View Seguril Review and Seguril Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CLOXACILLIN (View Cloxacillin Review and Cloxacillin Label ), URBASON (View Urbason Review and Urbason Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

6414145-8 | Stevens-johnson Syndrome
on Oct 15, 2009 Female patient from SPAIN , 68 years of age, was diagnosed with pyrexia, multiple myeloma (What is multiple myeloma?) and was treated with Tazocel (View Usage). After Tazocel was administered, patient had the following side effects: stevens-johnson syndrome. Tazocel dosage: . During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6345301-5 | Cardiogenic Shock, Hepatitis Cholestatic
Patient was taking Tazocel (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock, hepatitis cholestatic on Aug 31, 2009 from SPAIN Additional patient health information: Male patient , 69 years of age, . Tazocel dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), EDEMOX (View Edemox Review and Edemox Label ), TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ), AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), HIBOR (View Hibor Review and Hibor Label ).

6202687-X | Pancytopenia
Adverse event was reported on May 21, 2009 by a Female patient taking Tazocel (View Usage) (Dosage: ) was diagnosed with abdominal infection, pain (What is pain?), vomiting, depression (What is depression?), prophylaxis and. Location: SPAIN , 76 years of age, Patient had the following side effects: pancytopenia. During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), PRIMPERAN (View Primperan Review and Primperan Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), INYESPRIN (View Inyesprin Review and Inyesprin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ).

6129140-6 | Mixed Liver Injury
on Mar 18, 2009 Male patient from SPAIN , 86 years of age, was diagnosed with pneumonia (What is pneumonia?), type 2 diabetes mellitus, atrial fibrillation (What is atrial fibrillation?), cardiac failure, chronic obstructive pulmonary disease and was treated with Tazocel (View Usage). After Tazocel was administered, patient had the following side effects: mixed liver injury. Tazocel dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LANACORDIN (View Lanacordin Review and Lanacordin Label ), TAVANIC (View Tavanic Review and Tavanic Label ), SEGURIL (View Seguril Review and Seguril Label ), SERETIDE (View Seretide Review and Seretide Label ), SINTROM (View Sintrom Review and Sintrom Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ).

6123699-0 | Mixed Liver Injury
on Mar 18, 2009 Male patient from SPAIN , 86 years of age, was diagnosed with pneumonia (What is pneumonia?), type 2 diabetes mellitus, atrial fibrillation (What is atrial fibrillation?), cardiac failure, chronic obstructive pulmonary disease and was treated with Tazocel (View Usage). Patient experienced the following unwanted or unexpected effects: mixed liver injury. Tazocel dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LANACORDIN (View Lanacordin Review and Lanacordin Label ), TAVANIC (View Tavanic Review and Tavanic Label ), SEGURIL (View Seguril Review and Seguril Label ), SERETIDE (View Seretide Review and Seretide Label ), SINTROM (View Sintrom Review and Sintrom Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ).

6080606-7 | Hepatitis Cholestatic, Respiratory Disorder
Patient was taking Tazocel (View Usage). Patient had the following side effects: hepatitis cholestatic, respiratory disorder on Feb 13, 2009 from SPAIN Additional patient health information: Male patient , 56 years of age, was diagnosed with nosocomial infection and. Tazocel dosage: . During the same period patient was treated with ALMAX (View Almax Review and Almax Label ), BUSCAPINA (View Buscapina Review and Buscapina Label ), URBASON (View Urbason Review and Urbason Label ), ORFIDAL (View Orfidal Review and Orfidal Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), URBAL (View Urbal Review and Urbal Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), NULYTELY (View Nulytely Review and Nulytely Label ).

5945058-3 | Cardiac Arrest, Clostridium Difficile Colitis, Ileus Paralytic, Megacolon
Adverse event was reported on Oct 28, 2008 by a Female patient taking Tazocel (View Usage) (Dosage: ) was diagnosed with pneumonia aspiration and. Location: SPAIN , 71 years of age, After Tazocel was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), clostridium difficile colitis, ileus paralytic, megacolon. During the same period patient was treated with NALOXONE (View Naloxone Review and Naloxone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5894834-4 | Leukocytoclastic Vasculitis, Rash Maculo-papular
on Sep 19, 2008 Male patient from SPAIN , 49 years of age, weighting 154.3 lb, was treated with Tazocel (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis, rash maculo-papular. Tazocel dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CLEXANE (View Clexane Review and Clexane Label ), TARGOCID (View Targocid Review and Targocid Label ). Patient was hospitalized.

5875486-6 | Confusional State, Delirium
on Sep 05, 2008 Male patient from SPAIN , 85 years of age, was diagnosed with respiratory tract infection and was treated with Tazocel (View Usage). Patient had the following side effects: confusional state, delirium. Tazocel dosage: 2/0,25 G.

5841762-6 | Anaemia, Coagulopathy, Thrombocytopenia
Patient was taking Tazocel (View Usage). After Tazocel was administered, patient had the following side effects: anaemia, coagulopathy, thrombocytopenia on Aug 07, 2008 from SPAIN Additional patient health information: Female patient , 40 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Tazocel dosage: . During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ). Patient was hospitalized.

5797679-9 | Eosinophilia, Liver Injury, Lymphadenopathy, Lymphocyte Morphology Abnormal
Adverse event was reported on Jun 26, 2008 by a Female patient taking Tazocel (View Usage) (Dosage: ) was diagnosed with abdominal abscess and. Location: SPAIN , 43 years of age, Patient experienced the following unwanted or unexpected effects: eosinophilia, liver injury, lymphadenopathy, lymphocyte morphology abnormal.

5715860-1 | Bicytopenia, Leukopenia, Thrombocytopenia
on Apr 22, 2008 Male patient from SPAIN , 73 years of age, was diagnosed with nosocomial infection and was treated with Tazocel (View Usage). Patient had the following side effects: bicytopenia, leukopenia, thrombocytopenia. Tazocel dosage: . Patient was hospitalized.

5663248-4 | Arthralgia, Tendonitis
on Mar 05, 2008 Male patient from SPAIN , 39 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Tazocel (View Usage). After Tazocel was administered, patient had the following side effects: arthralgia, tendonitis. Tazocel dosage: 12.2 G. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ).

5626601-0 | Hepatocellular Injury, Hyperbilirubinaemia
Patient was taking Tazocel (View Usage). Patient experienced the following unwanted or unexpected effects: hepatocellular injury, hyperbilirubinaemia on Feb 06, 2008 from SPAIN Additional patient health information: Female patient , 30 years of age, was diagnosed with liver abscess, fascioliasis and. Tazocel dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ESKAZOLE (View Eskazole Review and Eskazole Label ).

5545412-8 | Hepatocellular Damage, Hyperbilirubinaemia
Adverse event was reported on Dec 05, 2007 by a Female patient taking Tazocel (View Usage) (Dosage: ) was diagnosed with liver abscess, fascioliasis and. Location: SPAIN , 30 years of age, Patient had the following side effects: hepatocellular damage, hyperbilirubinaemia. During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ESKAZOLE (View Eskazole Review and Eskazole Label ).

5467237-4 | Eosinophilia, Hepatocellular Damage
on Sep 20, 2007 Male patient from SPAIN , 66 years of age, was diagnosed with mycobacterium kansasii pneumonia, ischaemic heart disease prophylaxis, folate deficiency and was treated with Tazocel (View Usage). After Tazocel was administered, patient had the following side effects: eosinophilia, hepatocellular damage. Tazocel dosage: . During the same period patient was treated with ZYVOX (View Zyvox Review and Zyvox Label ), TROMALYT (300 Mg Every) (View Tromalyt Review and Tromalyt Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), ETAMBUTOL (1.6 G Every) (View Etambutol Review and Etambutol Label ), TAVANIC (View Tavanic Review and Tavanic Label ), BENADON (300 Mg Every) (View Benadon Review and Benadon Label ), RIFATER (5 Tablet Every) (View Rifater Review and Rifater Label ).

5450170-1 | Leukocytoclastic Vasculitis, Rash Maculo-papular
on Sep 04, 2007 Male patient from SPAIN , 49 years of age, weighting 154.3 lb, was treated with Tazocel (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis, rash maculo-papular. Tazocel dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), TARGOCID (View Targocid Review and Targocid Label ). Patient was hospitalized.

5388999-0 | Rash Maculo-papular, Vasculitis
Patient was taking Tazocel (View Usage). Patient had the following side effects: rash maculo-papular, vasculitis (What is vasculitis?) on Jul 12, 2007 from SPAIN Additional patient health information: Male patient , 49 years of age, weighting 154.3 lb, . Tazocel dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CLEXANE (View Clexane Review and Clexane Label ), TARGOCID (View Targocid Review and Targocid Label ). Patient was hospitalized.

5234360-9 | Discomfort, Haemolytic Anaemia, Hepatic Function Abnormal, Jaundice, Renal Impairment
Adverse event was reported on Feb 06, 2007 by a Male patient taking Tazocel (View Usage) (Dosage: ) was diagnosed with hyperventilation and. Location: SPAIN , 25 years of age, After Tazocel was administered, patient had the following side effects: discomfort, haemolytic anaemia, hepatic function abnormal, jaundice (What is jaundice?), renal impairment. During the same period patient was treated with COLISTIN (View Colistin Review and Colistin Label ). Patient was hospitalized.

5224717-4 | Haemolysis, Hypovolaemic Shock
on Jan 26, 2007 Female patient from SPAIN , 38 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Tazocel (View Usage). Patient experienced the following unwanted or unexpected effects: haemolysis, hypovolaemic shock. Tazocel dosage: . During the same period patient was treated with ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), COTRIM (View Cotrim Review and Cotrim Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.